日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway

SF3B1突变通过激活mTOR通路加速慢性淋巴细胞白血病(CLL)的进展。

Bo Zhang ,Prajish Iyer ,Meiling Jin ,Elisa Ten Hacken ,Zachary J Cartun ,Kevyn L Hart ,Mike Fernandez ,Kristen Stevenson ,Laura Rassenti ,Emanuela M Ghia ,Thomas J Kipps ,Donna Neuberg ,Ruben Carrasco ,Wing C Chan ,Joo Y Song ,Yu Hu ,Catherine J Wu ,Lili Wang

Cancer-associated SF3B1-K700E mutation controls immune responses by regulating Treg function via aberrant Anapc13 splicing

癌症相关的 SF3B1-K700E 突变通过异常 Anapc13 剪接调节 Treg 功能来控制免疫反应

Yun Shi, Wencan Zhang, Qiong Jia, Xiancai Zhong, Prajish Iyer, Hongmin Wu, Yate-Ching Yuan, Yuqi Zhao, Lianjun Zhang, Lili Wang, Zhenyu Jia, Ya-Huei Kuo, Zuoming Sun

SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation

SF3B1 突变和 ATM 缺失通过着丝粒 R 环失调共同驱动白血病形成

Martina Cusan, Haifeng Shen, Bo Zhang, Aijun Liao, Lu Yang, Meiling Jin, Mike Fernandez, Prajish Iyer, Yiming Wu, Kevyn Hart, Catherine Gutierrez, Sara Nik, Shondra M Pruett-Miller, Jeremy Stark, Esther A Obeng, Teresa V Bowman, Catherine J Wu, Ren-Jang Lin, Lili Wang

ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer

ERBB2 和 KRAS 变异介导早期胆囊癌对 EGFR 抑制剂的反应

Prajish Iyer, Shailesh V Shrikhande, Malika Ranjan, Asim Joshi, Nilesh Gardi, Ratnam Prasad, Bhasker Dharavath, Rahul Thorat, Sameer Salunkhe, Bikram Sahoo, Pratik Chandrani, Hitesh Kore, Bhabani Mohanty, Vikram Chaudhari, Anuradha Choughule, Dhananjay Kawle, Pradip Chaudhari, Arvind Ingle, Shripad

Integrated genomics approach to identify biologically relevant alterations in fewer samples

整合基因组学方法可在更少的样本中识别生物学相关改变

Pratik Chandrani, Pawan Upadhyay, Prajish Iyer, Mayur Tanna, Madhur Shetty, Gorantala Venkata Raghuram, Ninad Oak, Ankita Singh, Rohan Chaubal, Manoj Ramteke, Sudeep Gupta, Amit Dutt